The Coronavirus vaccine developed by US giant Pfizer and its German partner BioNTech is likely to be effective against a new key mutation that emerged in the UK, according to a study published online on Tuesday. The study, published on preprint server bioRxiv and not yet peer-reviewed found that antibodies found in the blood of 16 patients

who had received the Pfizer/BioNTech jab were able to neutralise a version of the new UK variant, the so-called B.1.187, which has “an unusual large” number of mutations with 10 amino acid changes in the spike protein, and is reported to be more contagious.

 

https://www.neweurope.eu/article/pfizer-biontech-vaccine-likely-to-protect-against-covid-variant/

 

Διαβάστε ακόμα